by Karl Denninger
Market-Ticker.org
This is what I’ve referenced repeatedly over the years, and many times with regard to Covid and multiple claims, whether it be masks, the PCR testing, other alleged mitigations and similar.
Too many of its findings that fill the academic ether are the result of shoddy experiments or poor analysis. … A rule of thumb among biotechnology venture capitalists is that half of published research cannot be replicated. Even that may be optimistic. Last year researchers at one biotech firm, Amgen, found they could reproduce just six of 53 “landmark” studies in cancer research. Earlier, a group at Bayer, a drug company, managed to repeat just a quarter of 67 similarly important papers. A leading computer scientist frets that three quarters of papers in his subfield are bunk. In 2000-10 roughly 80,000 patients took part in clinical trials based on research that was later retracted because of mistakes or improprieties.
Think about the scope of this problem. It is by no means limited to the medical field; indeed environmental matters are some of the worst, especially in the so-called “global warming” field.
As just one example we all know the oceans are connected bodies of water. That is, unlike a lake which may be impounded and thus rise and fall with the amount of rain, water drawn for irrigation or used to produce electricity independent of another lake a few miles away the oceans all connect to each other and as anyone who has ever put water into two containers connected together knows it will flow through the connection until they are both at the same level.